Translating Cell-Based Regenerative Medicines from Research to Successful Products: Challenges and Solutions-Reference-Cited by-同舟云学术

Translating Cell-Based Regenerative Medicines from Research to Successful Products: Challenges and Solutions

Published:2014-08 Issue:4 Volume:20 Page:246-256
ISSN:1937-3368
Container-title:Tissue Engineering Part B: Reviews
language:en
Short-container-title:Tissue Engineering Part B: Reviews

Author:

Bayon Yves¹,Vertès Alain A.²,Ronfard Vincent³,Egloff Matthieu⁴,Snykers Sarah⁵,Salinas Gabriella Franco⁶,Thomas Robert⁷,Girling Alan⁸,Lilford Richard⁸,Clermont Gaelle⁹,Kemp Paul¹⁰

Affiliation:

1. Covidien–Sofradim Production, Trévoux, France.

2. Sloan Fellow, London Business School, London, UK and NxR Biotechnologies GmbH, Basel, Switzerland.

3. Smith and Nephew Biotherapeutics, Fort Worth, Texas.

4. ATMI Life Science, rue de Ransbeek, Brussels, Belgium.

5. Promethera Biosciences, Rue Granbonpré, Mont-Saint-Guibert, Belgium.

6. PharmaCell, Process Development and Research, Maastricht, Netherlands.

7. Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University & EPSRC Centre for Regenerative Medicine, Loughborough, United Kingdom.

8. School of Health and Population Sciences, University of Birmingham, Birmingham, United Kingdom.

9. NAMSA, Chasse-sur-Rhône, France.

10. Intercytex Ltd Core Technology Facility, Manchester, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.teb.2013.0727

Reference25 articles.

1. The Regulatory Imperative: International Perspective

2. Commercialization of Regenerative Products: The Academic/Industry Partnership